ArticleScientific reports2025
Kiam wood, Cotylelobium lanceotatum, extract as a natural antimicrobial agent: protecting Pacific white shrimp, Penaeus vannamei, against vibriosis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Vibriosis, caused by Vibrio parahaemolyticus, is a major bacterial disease in shrimp aquaculture, often managed with antibiotics that contribute to antimicrobial resistance and environmental concerns. This study investigated the antimicrobial properties of Kiam wood (Cotylelobium lanceotatum) extract and its potential as a dietary supplement to enhance the disease resistance of Pacific white shrimp, Penaeus vannamei. Kiam wood extracts were prepared using ethanol-water mixture at different ratios, and their antimicrobial activity was evaluated against V. parahaemolyticus. The water extract (KWE) exhibited the strongest anti-Vibrio activity as indicated by the widest clearance zone (15.65 mm), with a minimum inhibitory concentration (MIC) of 256 µg/mL and a minimum bactericidal concentration (MBC) of 512 µg/mL. Further assays demonstrated that KWE effectively inhibited biofilm formation and restricted bacterial motility at 512 µg/mL (MBC). Scanning electron microscopic images revealed significant cell-wall damages in treated bacteria as shown by membrane disruption and pore formations. Liquid chromatography-mass spectrometry (LC-MS) analysis identified Amuresins D (C
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.